article thumbnail

The European Commission report on competition enforcement in the pharmaceutical sector

JD Supra: Mergers

On 26 January 2024, the European Commission published a report on competition enforcement in the pharmaceutical sector, highlighting the role of EU competition law in safeguarding market participants and consumers, particularly amid the challenges posed by the Covid-19 crisis.

article thumbnail

FTC and DOJ outline potential changes to agencies’ review of pharmaceutical mergers

JD Supra: Mergers

On June 1, 2023, the Federal Trade Commission (FTC) and the Antitrust Division of the US Department of Justice (DOJ) released a summary of a workshop jointly held by the agencies in June 2022 titled “Future of Pharmaceuticals: Examining the Analysis of Pharmaceutical Mergers.”

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FTC and DOJ Antitrust Memorialize Joint Workshop on the Future of Antitrust Enforcement in the Pharmaceutical Industry

JD Supra: Mergers

Department of Justice Antitrust Division, recently released a summary of the Agencies’ June 2022 joint workshop titled “The Future of Pharmaceuticals: Examining the Analysis of Pharmaceutical Mergers.” By: Mintz

article thumbnail

Nika Pharmaceuticals, Inc. (NKPH) Merges With Nika Biotechnology, Inc.

Global Newswire by Notified: M&A

Nika Pharmaceuticals, Inc. OTCMKTS: NKPH) announces its merger with Nika BioTechnology, Inc., effective as of March 1, 2024.

article thumbnail

PE-backed Alcami acquires Pacific Pharmaceutical Services

PE Hub

The post PE-backed Alcami acquires Pacific Pharmaceutical Services appeared first on PE Hub. Alcami is a contract development and manufacturing organization.

article thumbnail

Avista-backed Cosette Pharmaceuticals acquires women’s sexual health brand Vyleesi

PE Hub

The post Avista-backed Cosette Pharmaceuticals acquires women’s sexual health brand Vyleesi appeared first on PE Hub. The seller was Palatin Technologies Inc.

article thumbnail

Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria

Global Newswire by Notified: M&A

March 22, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it has acquired U.S. DEER PARK, Ill.,